A comparison of 3 Tesla MRI to 7 Tesla MRI for Evaluation of Prostate Suspicious Lesions. Assess the added diagnostic value of ultra-high-field (7T) MRI over the current clinical standard (3T MRI) in detecting and characterizing suspicious prostate lesions. Evaluate whether dynamic deuterated glucose-enhanced imaging at 7T can offer improved contrast without the use of gadolinium-based agents.
Age range
18 Years – 75 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
ROC analysis of diagnostic performance: 3T versus 7T MRI
Timeframe: Assessed at the time of MRI acquisition during the study imaging visit.
Sensitivity and Specificity of diagnostic performance: 3T versus 7T MRI
Timeframe: Assessed at the time of MRI acquisition during the study imaging visit.
Lesion conspicuity of diagnostic performance: 3T versus 7T MRI
Timeframe: Assessed at the time of MRI acquisition during the study imaging visit.
PI-RADS classification - The Prostate Imaging Reporting and Data System: 3T versus 7T MRI
Timeframe: Assessed at the time of MRI acquisition during the study imaging visit.
Quantitative imaging metrics of diagnostic performance: 3T versus 7T MRI
Timeframe: Assessed at the time of MRI acquisition during the study imaging visit.